Linden Advisors’s GeneDx Holdings WGS Stock Holding History

Linden Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-63,639	Closed	-$23.2M	–	756
2020 Q4	$23.2M	Buy	+63,639	New	+$22.2M	0.17%	87

Other funds holding WGS

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SB Management Abu Dhabi, United Arab Emirates $516M AUM 40.71% 1-Year Est. Return

Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Linden Advisors's WGS Position: Q1 2021 in Review

Linden Advisors sold out of GeneDx Holdings (WGS) in Q1 2021, closing a stake of 63,639 shares — an estimated $23.2M sold.

Linden Advisors first reported a position in WGS in Q4 2020 and held it in 1 quarter. The position peaked at $23.2M in Q4 2020. 67 funds tracked by Wall St. Rank hold WGS as of Q1 2021.

Linden Advisors reported no remaining GeneDx Holdings position as of Q1 2021 after selling out during the quarter.
Linden Advisors sold 63,639 GeneDx Holdings shares in Q1 2021, an estimated $23.2M.
Linden Advisors first reported a position in GeneDx Holdings in Q4 2020 and held it in 1 quarter.
Linden Advisors's GeneDx Holdings position peaked at $23.2M in Q4 2020.
67 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2021.

Based on Linden Advisors's 13F filing for Q1 2021, filed 17 May 2021.